When a cancer in the colon or rectum is called "stage 3," it means the cancer cells have spread beyond the bowel wall into nearby lymph nodes. Surgery to remove the visible tumor along with surrounding tissue and lymph nodes clears the biggest hurdle of treatment. Even so, the reason doctors often recommend chemotherapy afterward is not that the surgery failed — it is to address a risk that cannot be seen.
Surgery removes cancer that is visible to the eye and detectable on imaging, but it cannot guarantee the removal of cancer cells that may already have scattered in tiny amounts through the blood or lymph vessels (micrometastasis). When lymph nodes were involved, as in stage 3 disease, the chance that such cells remain is relatively higher. Chemotherapy given for a set period after surgery is called adjuvant chemotherapy, and its goal is to clear away any cells that might be left, lowering the risk of recurrence.
Adjuvant chemotherapy does not guarantee a cure; it reduces the statistical chance of the cancer coming back by a certain amount. How much benefit it offers depends on the number of involved lymph nodes, the features of the cancer cells, and the patient's overall condition, so it is worth asking the care team specifically what the expected benefit is in your own case. The medicines come in oral and intravenous forms, and two or three may be combined.
Being older is not, by itself, a reason to give up on treatment. Rather than age alone, heart and kidney function, everyday activity level, and other coexisting conditions matter more. When helpful, a geriatric assessment can gauge whether the body can tolerate treatment, and doses may be lowered or gentler regimens chosen to balance side effects against benefit.
When a patient hesitates or refuses, the feeling may blend fear of side effects, fatigue from recent surgery, and a sense of "why bother at my age." Instead of pushing, it often helps to first listen to what worries them most. Hearing from the care team what the benefits and burdens of treatment are — and what the risks of skipping it are — and taking a few days to think rather than deciding in a single conversation, can help. The decision should center on the patient's own wishes while family and clinicians share information and reach it together (shared decision making).
This article is for general information and is not a substitute for a diagnosis or treatment recommendation for any individual. Whether and how to have chemotherapy varies greatly with a person's stage and health, so please discuss your situation thoroughly with your care team before deciding.